Deep Vein Thrombosis (DVT) Clinical Trial
Official title:
Is Therapeutic Anticoagulation Necessary for the Treatment of Distal Deep Venous Thrombosis of the Lower Extremity? A Randomized, Controlled Trial
Hospitalized patients are at risk of developing blood clots in the legs (Deep Vein Thrombosis
or DVT), which can lead to death if those clots break off and migrate to the lungs. We know
that if there is a blood clot in the large leg veins near the hips and in the thighs,
treating these patients with high-doses of blood thinners reduces the risk of these deaths.
It is unclear if treating blood clots in the calf with high doses of blood thinners is better
than using low doses. In this study, after being diagnosed with a blood clot in the calf,
patients will be treated with either low dose or high dose enoxaparin (Lovenox), a blood
thinner. We will then see if low dose blood thinner has similar results as high dose blood
thinner.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT02523937 -
Evaluation of Soluble Fibrin in Thrombosis Exclusion
|
||
| Completed |
NCT00986154 -
Comparative Investigation of Low Molecular Weight (LMW) Heparin/Edoxaban Tosylate (DU176b) Versus (LMW) Heparin/Warfarin in the Treatment of Symptomatic Deep-Vein Blood Clots and/or Lung Blood Clots. (The Edoxaban Hokusai-VTE Study).
|
Phase 3 | |
| Completed |
NCT02205294 -
Osteopathic Treatment and Deep Vein Thrombosis (DVT)
|
N/A | |
| Completed |
NCT02798471 -
Hokusai Study in Pediatric Patients With Confirmed Venous Thromboembolism (VTE)
|
Phase 3 | |
| Completed |
NCT02210819 -
Treatment of Venous Thromboembolism (VTE) With Either Rivaroxaban or Current Standard of Care Therapy
|
||
| Completed |
NCT01630148 -
Bemiparin as a Thromboprophylaxis After Gynaecological Surgeries
|
N/A | |
| Completed |
NCT02073682 -
Cancer Venous Thromboembolism (VTE)
|
Phase 3 | |
| Recruiting |
NCT06195787 -
Improving Emergency Department Testing for Deep Vein Thrombosis
|
||
| Recruiting |
NCT02342444 -
Lovenox 30 mg Twice Daily (BID) Versus 40 mg Once Daily (QD)
|
Phase 4 | |
| Completed |
NCT02744092 -
Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in Cancer
|
N/A | |
| Recruiting |
NCT02156401 -
VTEval Project - Prospective Cohort Studies to Evaluate and Improve Diagnostics, Management Strategies and Risk Stratification in VTE
|